Tinnitus & Hyperacusis Center, Dept. of Otolaryngology, Emory University, 550 Peachtree Street NE Atlanta Georgia
Dr. Jastreboff is currently Professor at Department of Otolaryngology, Emory University School of Medicine. After 8 years at Yale University and 8 years at the University of Maryland, where he established the first Tinnitus & Hyperacusis Center in the USA, he moved to Emory University. In 1984 he proposed the first accepted animal model of tinnitus, in 1988 the neurophysiological model of tinnitus and Tinnitus Retraining Therapy (TRT). He is involved in clinical work and treating patients with tinnitus and / or decreased sound tolerance since 1990. Simultaneously with clinical work he has been conducting basic science and clinical research aimed at delineating the mechanisms of tinnitus and designing new methods of alleviation of tinnitus, hyperacusis and misophonia. In 2001, together with Margaret M. Jastreboff, Ph.D., he proposed concept, the name and the initial treatment for misophonia. Dr. Jastreboff received a Ph.D. in Neurophysiology (1973) and Doctor of Sciences Degree (habilitation, 1982) in Neuroscience from the Polish Academy of Sciences. He did his Postdoctoral training at the University of Tokyo, Japan. In 2005 he received M.B.A. (valedictorian) from Goizueta Business School at Emory University. He has been a Visiting Professor at University of Tokyo and at Yale University and currently holds Visiting Professor appointments at University College London and Middlesex Hospital, London, England. From 2001 until 2010, together with Margaret M. Jastreboff, Ph.D., he has been Adjunct Professor at Salus University teaching tinnitus and hyperacusis class in Au.D. program. 1954 audiologist (about 25% of all Au.D. degrees in the USA) took this class. He is a co-author of over 130 papers, 170 abstracts and three books. In 1993 he received the prestigious Robert W. Hocks award for his contribution to the field of tinnitus and in 2014, at 11th International Tinnitus Seminar the Award for Clinical Excellence, for 25 years work of TRT.